Acro Biomedical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Revenue	-	-	-	0.66	1.2	Upgrade
Revenue Growth (YoY)	-	-	-	-45.01%	74.06%	Upgrade
Cost of Revenue	-	-	-	0.52	0.94	Upgrade
Gross Profit	-	-	-	0.14	0.26	Upgrade
Selling, General & Admin	0.15	0.04	3.52	5.93	2.67	Upgrade
Research & Development	-	-	4.79	10.08	5.29	Upgrade
Operating Expenses	0.15	0.04	8.79	16.01	7.95	Upgrade
Operating Income	-0.15	-0.04	-8.79	-15.87	-7.69	Upgrade
Interest Expense	-0.01	-0	-0	-0	-0	Upgrade
EBT Excluding Unusual Items	-0.16	-0.04	-8.8	-15.87	-7.7	Upgrade
Asset Writedown	-	-	-0.01	-	-	Upgrade
Other Unusual Items	0.06	-	-	-	-	Upgrade
Pretax Income	-0.1	-0.04	-8.81	-15.87	-7.7	Upgrade
Net Income	-0.1	-0.04	-8.81	-15.87	-7.7	Upgrade
Net Income to Common	-0.1	-0.04	-8.81	-15.87	-7.7	Upgrade
Shares Outstanding (Basic)	60	60	60	60	54	Upgrade
Shares Outstanding (Diluted)	60	60	60	60	54	Upgrade
Shares Change (YoY)	-	-	-	11.52%	12.73%	Upgrade
EPS (Basic)	-0.00	-0.00	-0.15	-0.26	-0.14	Upgrade
EPS (Diluted)	-0.00	-0.00	-0.15	-0.26	-0.14	Upgrade
Gross Margin	-	-	-	21.34%	21.67%	Upgrade
Operating Margin	-	-	-	-2409.98%	-642.47%	Upgrade
Profit Margin	-	-	-	-2410.24%	-642.83%	Upgrade
EBIT	-0.15	-0.04	-8.79	-15.87	-7.69	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.